Overexpression of Pyruvate Dehydrogenase Kinase-3 Predicts Poor Prognosis in Urothelial Carcinoma

Overexpression of Pyruvate Dehydrogenase Kinase-3 Predicts Poor Prognosis in Urothelial Carcinoma

BackgroundThe mitochondrial pyruvate dehydrogenase complex (PDC) link glycolysis to the tricarboxylic acid cycle by decarboxylating pyruvate to acetyl coenzyme A irreversibly. Cancer cells are characterized by a shift in cellular metabolism from mitochondrial respiration to glycolysis. PDC activity...

Full description

Bibliographic Details
Main Authors:	Yu-Hsuan Kuo, Ti-Chun Chan, Hong-Yue Lai, Tzu-Ju Chen, Li-Ching Wu, Chung-Hsi Hsing, Chien-Feng Li
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-09-01
Series:	Frontiers in Oncology
Subjects:	pyruvate dehydrogenase kinase-3 urothelial carcinoma of the bladder urothelial carcinoma of upper urinary tract cancer metabolism metabolic reprogramming
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2021.749142/full

Similar Items

Angiogenesis Driven by the CEBPD–hsa-miR-429–VEGFA Signaling Axis Promotes Urothelial Carcinoma Progression
by: Ti-Chun Chan, et al.
Published: (2022-02-01)

The biological impacts of CEBPD on urothelial carcinoma development and progression
by: Ti-Chun Chan, et al.
Published: (2023-01-01)

Low expression of ZSCAN4 predicts unfavorable outcome in urothelial carcinoma of upper urinary tract and urinary bladder
by: Hong-Lin He, et al.
Published: (2023-02-01)

Current Development and Application of Anaerobic Glycolytic Enzymes in Urothelial Cancer
by: Yi-Fang Yang, et al.
Published: (2021-09-01)

Pyruvate dehydrogenase kinase regulates macrophage polarization in metabolic and inflammatory diseases
by: Chenyu Li, et al.
Published: (2023-12-01)

High Stromal SFRP2 Expression in Urothelial Carcinoma Confers an Unfavorable Prognosis
by: Hong-Yue Lai, et al.
Published: (2022-03-01)

Upregulation of dihydropyrimidinase-like 3 (DPYSL3) protein predicts poor prognosis in urothelial carcinoma
by: Peir-In Liang, et al.
Published: (2023-06-01)

Renal Collecting Duct Carcinoma and Concomitant Bladder Urothelial Carcinoma: A Case Report
by: Hsi-Lin Hsiao, et al.
Published: (2008-03-01)

Prognostic Role of Serum Lactate Dehydrogenase in Patients With Urothelial Carcinoma: A Systematic Review and Meta-Analysis
by: Minhong Wu, et al.
Published: (2020-05-01)

Role of Microtubule-Associated Protein 1b in Urothelial Carcinoma: Overexpression Predicts Poor Prognosis
by: Tsu-Ming Chien, et al.
Published: (2020-03-01)

Chemotherapy of Locally Advanced or Metastatic Urothelial Cell Carcinoma: Monocentric Real-Life Data
by: Fischer C, et al.
Published: (2020-06-01)

Urothelial carcinoma; an overview of histology, molecular subtypes, and clinical implications based on the latest WHO classification
by: Fateme Khalatbari, et al.
Published: (2023-09-01)

Utility of EFEMP1 in the Prediction of Oncologic Outcomes of Urothelial Carcinoma
by: Tzu-Ju Chen, et al.
Published: (2021-06-01)

Complete Response of Rare Sarcomatoid Upper Tract Urothelial Carcinoma Variant: Case Report and Literature Review
by: Syah Mirsya Warli, et al.
Published: (2023-05-01)

Metformin is associated with better survival rate of localized upper tract urothelial carcinoma patients with type 2 diabetes
by: Chung-Yu Lin, et al.
Published: (2023-01-01)

Downregulation of CRTAC1 in Urothelial Carcinoma Promotes Tumor Aggressiveness and Confers Poor Prognosis
by: Wei-Ming Li, et al.
Published: (2023-09-01)

Platelet Mitochondrial Bioenergetics Reprogramming in Patients with Urothelial Carcinoma
by: Patrik Palacka, et al.
Published: (2021-12-01)

Orbital Metastasis from Urothelial Carcinoma of the Urinary Bladder
by: Han-Ching Lin, et al.
Published: (2007-02-01)

Editorial: Prognostic Research and Precision Oncology in Upper Tract Urothelial Carcinoma
by: Zai-Lin Sheu, et al.
Published: (2022-06-01)

Pyruvate dehydrogenase kinase 1–dependent metabolic reprogramming: A promising target for postmenopausal osteoporosis treatment
by: Dingbang Xie, et al.
Published: (2023-04-01)

Prognostic Significance of ROR2 Expression in Patients with Urothelial Carcinoma
by: Cheng-Fa Yeh, et al.
Published: (2021-08-01)

Pyruvate Dehydrogenase Kinases: Therapeutic Targets for Diabetes and Cancers
by: Nam Ho Jeoung
Published: (2015-06-01)

Clinical Efficacy of Adjuvant Chemotherapy in Advanced Upper Tract Urothelial Carcinoma (pT3-T4): Real-World Data from the Taiwan Upper Tract Urothelial Carcinoma Collaboration Group
by: Chung-Yu Lin, et al.
Published: (2022-02-01)

Updates on the Pivotal Roles of Mitochondria in Urothelial Carcinoma
by: Chiang-Chi Huang, et al.
Published: (2022-10-01)

Poor Outcome due to the Plasmacytoid Variant of Urothelial Carcinoma
by: Kyotaro Fukuta, et al.
Published: (2022-03-01)

HuR cytoplasmic expression is associated with increased cyclin A expression and poor outcome with upper urinary tract urothelial carcinoma
by: Liang Peir-In, et al.
Published: (2012-12-01)

Upper Tract Urothelial Carcinoma: A Narrative Review of Current Surveillance Strategies for Non-Metastatic Disease
by: Jakob Klemm, et al.
Published: (2023-12-01)

Characteristics and survival of primary urothelial carcinoma of the prostate: A multi-center retrospective study of 18 cases
by: Junjie Ji, et al.
Published: (2024-01-01)

Primary Urothelial Carcinoma of the Anterior Urethra
by: McGeorge Stephen, et al.
Published: (2019-12-01)

Incidences and oncological outcomes of urothelial carcinoma in kidney transplant recipients
by: Yu J, et al.
Published: (2018-12-01)

Stromal Lymphoid Response Status in Micropapillary Urothelial Carcinomas Diagnosed in Bladder Transurethral Resections and its Comparison with Conventional Urothelial Carcinomas
by: Ezgi HACIHASANOĞLU, et al.
Published: (2021-01-01)

Incidental upper tract urothelial carcinoma presenting as pyonephrosis
by: K Manjula, et al.
Published: (2017-01-01)

Molecular subtype classification of urothelial carcinoma in Lynch syndrome
by: Christina Therkildsen, et al.
Published: (2018-08-01)

TGFB1I1 promotes cell proliferation and migration in urothelial carcinoma
by: Peir‐In Liang, et al.
Published: (2024-03-01)

Role of Bladder Cancer Metabolic Reprogramming in the Effectiveness of Immunotherapy
by: Mathijs P. Scholtes, et al.
Published: (2021-01-01)

Metabolic and Molecular Basis of Sarcopenia: Implications in the Management of Urothelial Carcinoma
by: Hiroshi Fukushima, et al.
Published: (2019-02-01)

Immunohistochemical expression of β-Catenin in urinary bladder urothelial carcinoma
by: Fatma-Elzhraa A. Sherkawy*, et al.
Published: (2021-01-01)

Urothelial Carcinoma of the Ureter in a Patient with Functional Single Kidney
by: Farzaneh Shariiaghdas, et al.
Published: (2012-03-01)

Remarkable response to fluorouracil, leucovorin, oxaliplatin, and irinotecan therapy in urothelial cancer of the renal pelvis: a case report
by: Takuya Tsujino, et al.
Published: (2017-04-01)

Identification of tryptophan metabolism- and immune-related genes signature and prediction of immune infiltration landscape in bladder urothelial carcinoma
by: Guanwen Zhou, et al.
Published: (2023-10-01)